跳至主要内容
临床试验/CTRI/2023/01/048707
CTRI/2023/01/048707尚未招募未知

Role of rTMS as an adjunctive treatment in treatment resistant OCD :A randomized double blind and sham control trial.

Dr Kartikeya R Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex aged between 18 to 60 years.
  • Diagnosed cases of treatment resistant Obsessive compulsive disorder. Normotensive patients.
  • Age range:- 18- 60 years
  • Patients who gave written informed consent.

排除标准

  • Patients unwilling to participate in the study or dropped out during study period.
  • Current neurological or any comorbid psychiatric disorder.
  • History of epilepsy, significant head injury, drug abuse or any neurosurgical procedure, hypertension.
  • Subjects positive for TMS Adult Safety Screen (TASS) including individuals with cardiac pacemaker or metal in head.
  • Subjects who received ECT (Electro Convulsive Therapy) or antipsychotics in past 6 months.

研究者

发起方
Dr Kartikeya R Singh

相似试验